Login
Super Investors / Direxion Moonshot Innovators ETF

Direxion Moonshot Innovators ETF

Direxion Shares ETF Trust · net assets $21.7M · 49 holdings as of April 30, 2024. Monthly N-PORT disclosure: the full book, not just equities.

Asset mix

EC: 80.6% · STIV: 19.4%

Financial position

Total assets
$21.8M
Total liabilities
$6.56K
Net assets
$21.7M
Assets attributable to miscellaneous securities
$0
Assets invested in controlled foreign corporations
$0
Borrowings payable within one year
$0
Payable to controlled companies within one year
$0
Payable to other affiliates within one year
$0
Other liabilities payable within one year
$0
Borrowings payable after one year
$0
Payable to controlled companies after one year
$0
Payable to other affiliates after one year
$0
Other liabilities payable after one year
$0
Payables for delayed-delivery investments
$0
Payables for standby commitments
$0
Liquidation preference of outstanding preferred stock
$0
Cash not reported in Parts C or D
$0

Monthly flows and gains

Month 1 Month 2 Month 3
Sales $809K $535K $724K
Reinvestment $0 $0 $0
Redemptions $1.28M $1.89M $501K
Net realized gain (non-derivative) $-143K $169K $-1.34M
Net unrealized appreciation (non-derivative) $3.31M $-696K $-2.71M

The three months of the reporting period, as filed; month 3 ends April 30, 2024.

Filing details

Registrant
Direxion Shares ETF Trust
Registrant CIK
1424958
Registrant LEI
549300M501IVJM50FG12
Series
Direxion Moonshot Innovators ETF
Series ID
S000069290
Series LEI
549300DKAIOINSP63818
SEC file number
811-22201
Address
1301 Avenue of the Americas (6th Avenue), 28th Floor, New York, US-NY, 10019, US
Phone
646-572-3390
Form
NPORT-P
Filed
June 28, 2024
Report period ends
October 31, 2024
Report month ends
April 30, 2024
Accession number
000114554924041557
Holding Value % of net assets
Dreyfus Government Cash Manage STIV $5.22M 24.02%
Avidity Biosciences Inc. EC $1.61M 7.42%
4d Molecular Therapeutics Inc EC $891K 4.10%
Rumble Inc EC $816K 3.75%
Coinbase Global Inc EC $804K 3.70%
Robinhood Markets Inc EC $776K 3.57%
Squarespace Inc EC $656K 3.01%
Couchbase Inc EC $643K 2.96%
Aurora Innovation Inc EC $596K 2.74%
Roivant Sciences Ltd EC $590K 2.71%
Allogene Therapeutics Inc EC $572K 2.63%
Bilibili Inc. EC $571K 2.63%
Recursion Pharmaceuticals Inc EC $559K 2.57%
Ehang Holdings Limited EC $554K 2.55%
Nano Dimnsion Ltd EC $541K 2.49%
Snap Inc EC $541K 2.49%
Ouster Inc EC $539K 2.48%
Jumia Technologies Ag EC $490K 2.25%
Sentinelone Inc EC $481K 2.21%
Sofi Technologies Inc EC $456K 2.10%
Ambarella Inc EC $427K 1.96%
C3.ai Inc EC $410K 1.88%
Unity Software Inc EC $409K 1.88%
Asana Inc EC $406K 1.87%
Indie Semiconductor Inc. EC $406K 1.87%
Vimeo Inc EC $401K 1.85%
Fastly Inc. EC $396K 1.82%
Crispr Therapeutics Ag EC $395K 1.82%
Intellia Therapeutics Inc EC $380K 1.75%
Eos Energy Enterprises Inc. EC $373K 1.71%
Ginkgo Bioworks Holdings Inc EC $364K 1.67%
Upstart Holdings Inc EC $344K 1.58%
Innoviz Technologies Ltd EC $341K 1.57%
Nikola Corp. EC $335K 1.54%
Bigcommerce Holdings Inc EC $326K 1.50%
Lucid Group Inc EC $308K 1.41%
Planet Labs Pbc EC $307K 1.41%
Luminar Technologies Inc EC $301K 1.38%
Microvision Inc. EC $276K 1.27%
Xperi Inc. EC $272K 1.25%
Butterfly Network Inc EC $263K 1.21%
Verve Therapeutics Inc EC $255K 1.17%
Rekor Systems Inc. EC $252K 1.16%
Editas Medicine Inc EC $249K 1.14%
Virgin Galactic Holdings Inc EC $229K 1.05%
Lanzatech Global Inc EC $177K 0.81%
Ballard Power Systems Inc. EC $175K 0.80%
Vuzix Corp. EC $125K 0.57%
Bluebird Bio Inc EC $97.5K 0.45%

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support